In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

The conventional view holds that functional mitral regurgitation (MR) is caused by restriction
of leaflet motion resulting from displacement of the papillary muscle-bearing segments of the …

Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

Background Guidelines recommend prioritizing treatment with antiarrhythmic drugs before
referral of patients with atrial fibrillation to ablation, delaying a potential subsequent ablation …

Background This study investigates the relationship between triglyceride-glucose (TyG)
index trajectories and the results of ablation in patients with stage 3D atrial fibrillation (AF) …

Background Diagnosis-to-ablation time (DAT) strongly predicts recurrence of atrial fibrillation
(AF) after ablation. Whether this association holds with any lower and/or upper limits is …

© Heart Rhythm Society, the European Society of Cardiology, the Asia Pacific Heart Rhythm
Society, and the Latin American Heart Rhythm Society 2024. The articles are identical …

Aims Prior studies suggest that sodium–glucose cotransporter-2 inhibitors (SGLT2is) may
decrease the incidence of atrial fibrillation (AF). However, it is unknown whether SGLT2i can …

Background Population‐based data on heart failure (HF)‐related death in patients with atrial
fibrillation (AF) are lacking. We assessed HF‐related death in people with AF in the United …

Background Nonrandomized data suggest that longer diagnosis-to-ablation time (DAT) is
associated with poorer outcomes; however, a recent randomized trial found no difference in …